Mariners Flush Deadline Losses, Activate Donovan and Ward

The Seattle Mariners executed seven roster moves Tuesday, cutting ties with catcher Mitch Garver and outfielder Rob Refsnyder while absorbing Taylor Ward and Seranthony Domínguez from Monday's trade deadline deals. The moves read as organizational triage—dumping two veteran signings that failed to produce and clearing roster space for reinforcements that actually move the needle.

Garver's departure is the cleaner story. The 35-year-old catcher signed a minor league deal in February and appeared in 50 games hitting .175 with four home runs and 15 RBIs. Those numbers don't tell the whole picture; they tell you everything. A backup catcher who doesn't hit is ballast, not insurance. Cal Raleigh remains Seattle's primary backstop, and Jhonny Pereda, recalled from Triple-A Tacoma, takes over the secondary role at .270 with double-digit games played—a material upgrade in floor talent. Refsnyder's release stings slightly more because it represents failed expectation. Signed to a one-year deal last December as a depth outfielder and occasional starter, the 35-year-old appeared in 53 games hitting .140 with four home runs and 11 RBIs. A June 29 to July 27 IL stint for right knee inflammation—roughly four weeks out—didn't help his limited offensive window. By the time he returned, his performance had already circled the drain.

The real news is what Seattle acquired. Ward, 32, arrived from Baltimore in exchange for three pitching prospects (Hoppe, Moore, Kreiling) and carries legitimate leverage in the late-season gauntlet. In 111 games this season, he's hitting .246 with 20 doubles, seven home runs, and an AL-leading 87 walks. That walk total is the tell: Ward has a discerning eye and consistent contact quality that translates to secondary offense even when his batting average lags. The Orioles essentially scouted him out of a playoff picture; Seattle is betting his plate discipline anchors scoring in September. Domínguez, the 31-year-old right-hander acquired on Monday, slots into the bullpen at 4-3 with a 3.99 ERA across 43 games—mid-rotation depth and possible high-leverage optionality if Seattle's pen implodes.

Brendan Donovan's activation from a May 15 left groin strain represents the only surprising calendar move. The 2025 All-Star utility infielder has been sidelined for nearly 11 weeks, but appears ready for a full workload given he's back in the lineup. Over 25 games pre-injury this season, Donovan hit .274 with three home runs and four doubles. His return tightens Seattle's middle-infield options and adds a proven bat that doesn't require a deadline acquisition. From a betting lens, Donovan's return matters more to team total volatility than either Ward or Domínguez. A lineup that's been thinned by injuries gets a disciplined contact hitter back in the order. If he's healthy and maintains his pre-injury pace, Seattle's runs-per-game baseline lifts measurably over the final two months. Ward's walk rate should also suppress strikeout opportunities and boost BABIP stability in a suddenly deeper batting order. Team totals that priced Seattle as a wounded roster before Monday's deadline now face a ceiling shift—the market hasn't fully adjusted to Donovan's health status combined with Ward's plate discernment.

The deeper edge: Seattle's pitching depth and bullpen usage also shift. A healthier offensive core means fewer games decided by attrition or blown leads in the sixth inning. Domínguez adds strikeout risk to what was a vulnerable bullpen, but the real effect is marginal—relief ERA props for Seattle hold steady at current levels because Domínguez's 3.99 ERA sits slightly above Seattle's current pen average. Watch team totals against sub-.500 opponents over the next three weeks; Donovan and Ward's returns create positive variance that the market had priced as injury risk.